Viewing Study NCT00087633


Ignite Creation Date: 2025-12-25 @ 3:02 AM
Ignite Modification Date: 2026-02-25 @ 7:27 PM
Study NCT ID: NCT00087633
Status: COMPLETED
Last Update Posted: 2018-03-29
First Post: 2004-07-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: PHOENIX Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) Administered After Liver Transplantation for Hepatitis C.
Sponsor: Hoffmann-La Roche
Organization: